Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ANZTPA consultation "showing results":

This article was originally published in Clinica

Executive Summary

The emphasis on consultation with industry in the latest joint agency meeting has already paid off, Faye Sumner, CEO of the medical industry association of New Zealand (MIANZ), has told Clinica. "Already this has produced the announcement that third-party conformity certification for domestic companies will be recognised," she said. However, she remains cautious in her expectations: "It is encouraging, but we await the details. There have to be further changes to the current rules before MIANZ can support the draft [ANZTPA] legislation," she said. In this, she echoes the sentiments of her Australian counterpart, Brian Vale (see Clinica No 1222, p 14).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052851

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel